Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11945834 Cyclic dinucleotides as anticancer agents

Patent 11945834 was granted and assigned to Bristol-Myers Squibb Company on April, 2024 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

Bristol-Myers Squibb Company

Current Assignee

Bristol-Myers Squibb Company

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

119458340

Patent Inventor Names

Zheming Ruan0

Brian E. Fink0

Date of Patent

April 2, 2024

Patent Application Number

169782080

Date Filed

March 7, 2019

Patent Citations

‌

US Patent 11427610 Cyclic dinucleotides as anticancer agents

‌

US Patent 10106574 Cyclic di-nucleotide compounds as sting agonists

‌

US Patent 10519188 Cyclic di-nucleotide compounds and methods of use

‌

US Patent 10947263 Cyclic dinucleotides as anticancer agents

‌

US Patent 10953032 Cyclic dinucleotides as anticancer agents

‌

US Patent 11660311 Cyclic dinucleotides as anticancer agents

Patent Primary Examiner

CPC Code

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11945834 Cyclic dinucleotides as anticancer agents

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API